Antibiotic access is often framed as a choice between overuse and underuse. But the real challenge is optimal use: getting the right treatment to the right people at the right time.. 📅 Join GARDP on 27 October at 12:00 PM CET for a timely webinar exploring whether antibiotic use reflects resistance levels, disease burden and local realities, and what it takes to deliver effective treatments to high-burden populations. We’ll also examine GARDP’s public-private partnership model in action, including the recent approval of zoliflodacin in Thailand, just six months after its US FDA approval. 🔗 Join the conversation and register: attendee.gotowebinar.com/reg… #AntibioticAccess #AMR #GlobalHealth